Roland Schött

Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Ari Chaouat, Anne-Sophie Bugnet, Nabila Kadaoui et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 724 citations

A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients

Ari Chaouat, E Weitzenblum, Romain Kessler et al. · European Respiratory Journal · 1999 · 271 citations · Full text

Sleep Medicine, Sleep, Control Group +13

Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study

Benjamin Besse, Sylvestre Le Moulec, Julien Mazières et al. · Clinical Cancer Research · 2015 · 224 citations

Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial

Nathalie Baize, I. Monnet, Laurent Greillier et al. · The Lancet Oncology · 2020 · 145 citations

Second-line Treatment, Medicine, Pathology +7

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF

Bruno Chauffert, L. Feuvret, Franck Bonnetain et al. · Annals of Oncology · 2014 · 94 citations · Full text

Temavir Study, Neuro-oncology, Temozolomide-based Chemoradiation +11